AT295547B - Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen - Google Patents

Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen

Info

Publication number
AT295547B
AT295547B AT110370A AT110370A AT295547B AT 295547 B AT295547 B AT 295547B AT 110370 A AT110370 A AT 110370A AT 110370 A AT110370 A AT 110370A AT 295547 B AT295547 B AT 295547B
Authority
AT
Austria
Prior art keywords
azetidin
acyloxy
ones
preparation
new
Prior art date
Application number
AT110370A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AT295547B publication Critical patent/AT295547B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S8/00Bleaching and dyeing; fluid treatment and chemical modification of textiles and fibers
    • Y10S8/916Natural fiber dyeing
    • Y10S8/918Cellulose textile
AT110370A 1969-02-08 1970-02-06 Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen AT295547B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691906401 DE1906401A1 (de) 1969-02-08 1969-02-08 Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen

Publications (1)

Publication Number Publication Date
AT295547B true AT295547B (de) 1972-01-10

Family

ID=5724729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT110370A AT295547B (de) 1969-02-08 1970-02-06 Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen

Country Status (9)

Country Link
US (1) US3663535A (de)
JP (1) JPS4813549B1 (de)
AT (1) AT295547B (de)
BE (1) BE745692A (de)
CH (1) CH533103A (de)
DE (1) DE1906401A1 (de)
FR (1) FR2035206A5 (de)
GB (1) GB1249605A (de)
NL (1) NL7001507A (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199630A1 (de) * 1985-04-10 1986-10-29 Merck & Co. Inc. Substituierte Azetidinone, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von entzündungshemmenden und antidegenerativen Medikamenten
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229510A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. β-lactams useful in determining the amount of elastase in a clinical sample
US5348953A (en) * 1991-06-25 1994-09-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5591737A (en) * 1992-12-17 1997-01-07 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
US5952321A (en) * 1992-10-27 1999-09-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK329381A (da) * 1980-07-24 1982-01-25 Takeda Chemical Industries Ltd Fremgangsmaade til frmstilling af 1,1-disubstitueret carba-z -penem samt salte og estere deraf
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229510A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. β-lactams useful in determining the amount of elastase in a clinical sample
EP0199630A1 (de) * 1985-04-10 1986-10-29 Merck & Co. Inc. Substituierte Azetidinone, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von entzündungshemmenden und antidegenerativen Medikamenten
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5348953A (en) * 1991-06-25 1994-09-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5952321A (en) * 1992-10-27 1999-09-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5591737A (en) * 1992-12-17 1997-01-07 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
BE745692A (fr) 1970-08-10
FR2035206A5 (de) 1970-12-18
US3663535A (en) 1972-05-16
NL7001507A (de) 1970-08-11
DE1906401A1 (de) 1970-08-27
CH533103A (de) 1973-01-31
JPS4813549B1 (de) 1973-04-27
GB1249605A (en) 1971-10-13

Similar Documents

Publication Publication Date Title
AT303055B (de) Verfahren zur Herstellung von neuen β-Aryl-2-aminoalkoxy-styrolen
AT298452B (de) Verfahren zur Herstellung von neuen Aminoalkylphenolen
AT299924B (de) Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT313292B (de) Verfahren zur Herstellung von neuen 4-heterosubstituierten Azetidinonen-(2)
AT295547B (de) Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen
AT317249B (de) Verfahren zur Herstellung von neuen Dialkyl-xanthin-Derivaten
CH520706A (de) Verfahren zur Herstellung von neuen Bezothiazepinderivaten
AT303751B (de) Verfahren zur Herstellung von neuen Amidophenylguanidinen
AT294110B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-pyridaziniumverbindungen
AT305987B (de) Verfahren zur Herstellung von neuen Aminoketonen
CH529141A (de) Verfahren zur Herstellung von neuen 6-Hydrazino-Pyridazinen
AT293411B (de) Verfahren zur Herstellung von neuen 2-Alkyl-pyridazoniumverbindungen
CH540899A (de) Verfahren zur Herstellung von neuen Neriifolin-Derivaten
AT295485B (de) Verfahren zur Herstellung von neuen N-substituierten γ-Cyanbutyraldiminen
AT301053B (de) Verfahren zur Herstellung von neuen 14β-Hydroxy-15α-acyloxy-cardenoliden
AT299925B (de) Verfahren zur Herstellung von neuen 1-Amino-anthrachinonen
AT296333B (de) Verfahren zur Herstellung von neuen 4-Oxaphosphorinanen
AT299952B (de) Verfahren zur Herstellung von neuen substituierten 2-Azabicycloalkanen
AT296300B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-5,6-dihydro-4H-pyranen
AT303255B (de) Verfahren zur Herstellung von neuen Acylaminopenicillansäuren
AT300216B (de) Verfahren zur Herstellung von neuen d-18-Methyl-17α-alkinyl-4-östren-17β-olen
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
CH518943A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkyl-benzolsulfonamids
AT311306B (de) Verfahren zur Herstellung von neuen N-substituierten N-Thioformyl-hydroxylaminen
CH507929A (de) Verfahren zur Herstellung von neuen B-Methylglycidylaminen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee